Discontinuation of hydroxychloroquine in older patients with systemic lupus erythematosus: a multicenter retrospective study

BACKGROUND: Although hydroxychloroquine (HCQ) is a mainstay of treatment for patients with systemic lupus erythematosus (SLE), ocular toxicity can result from accumulated exposure. As the longevity of patients with SLE improves, data are needed to balance the risk of ocular toxicity and the risk of...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernandez-Ruiz, Ruth, Bornkamp, Nicole, Kim, Mimi Y., Askanase, Anca, Zezon, Anna, Tseng, Chung-E, Belmont, H. Michael, Saxena, Amit, Salmon, Jane E., Lockshin, Michael, Buyon, Jill P., Izmirly, Peter M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7430013/
https://www.ncbi.nlm.nih.gov/pubmed/32807233
http://dx.doi.org/10.1186/s13075-020-02282-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7430013/
https://www.ncbi.nlm.nih.gov/pubmed/32807233
http://dx.doi.org/10.1186/s13075-020-02282-0

Ejemplares similares